t(9;11) (p21-22;q23); (MLL-AF9), PCR QUALITATIVE
Chromosomal rearrangements can produce tumorigenic fusion genes. This mechanism is seen in 15-25% of Leukemias, Lymphomas & Sarcomas. Fusions can be produced by translocations, inversions or deletions. Specific gene fusions in a patient's tumor cells have an important bearing on the management & prognosis. This assay detects MLL-AF9 fusion gene which is the most common MLL abnormality in AML.
Parameter(s) covered : 1
Report Frequency: Sample Mon / Thu 11 am; Report Wed / Sat
Special Instruction: Physician prescription is mandatory.
Price : ₹ 3500.00
Parameters
- t (9;11) (p21-22;q23); (MLL-AF9)